Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression

Autor:	Obermannová, R. 1, *, Van Cutsem, E. 2, Yoshino, T. 3, Bodoky, G. 4, Prausová, J. 5, Garcia-Carbonero, R. 6, Ciuleanu, T. 7, Garcia Alfonso, P. 8, Portnoy, D. 9, Cohn, A. 10, Yamazaki, K. 11, Clingan, P. 12, Lonardi, S. 13, Kim, T.W. 14, Yang, L. 15, Nasroulah, F. 16, Tabernero, J. 17
Zdroj:	In Annals of Oncology November 2016 27(11):2082-2089
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu